AKA: aDT-f (Cachero 2010)

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LH_L | 61 | 17.9% | 4.67 | 1,552 | 97.8% |
| AL_L | 280 | 82.1% | -3.27 | 29 | 1.8% |
| MB_PED_L | 0 | 0.0% | inf | 5 | 0.3% |
| LAL_L | 0 | 0.0% | inf | 1 | 0.1% |
| upstream partner | # | NT | conns CB3447 | % In | CV |
|---|---|---|---|---|---|
| VP1d_il2PN (R) | 1 | ACh | 70 | 21.3% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 51 | 15.5% | 0.0 |
| CB3447 (L) | 1 | GABA | 18 | 5.5% | 0.0 |
| ALIN5 (R) | 1 | GABA | 16 | 4.9% | 0.0 |
| v2LN5 (L) | 2 | Glu | 15 | 4.6% | 0.2 |
| CB1546 (L) | 2 | GABA | 14 | 4.3% | 0.4 |
| vLN25 (L) | 2 | Glu | 11 | 3.3% | 0.3 |
| M_l2PNm15 (L) | 1 | ACh | 10 | 3.0% | 0.0 |
| HRN_VP1d (L) | 6 | ACh | 10 | 3.0% | 0.7 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 9 | 2.7% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 8 | 2.4% | 0.0 |
| vLN27 (L) | 1 | Unk | 7 | 2.1% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 6 | 1.8% | 0.3 |
| LHPV2g1 (L) | 2 | ACh | 5 | 1.5% | 0.2 |
| lLN1_bc (L) | 4 | Unk | 5 | 1.5% | 0.3 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 4 | 1.2% | 0.0 |
| CB3417 (L) | 3 | Unk | 4 | 1.2% | 0.4 |
| CB1182 (L) | 1 | ACh | 3 | 0.9% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 3 | 0.9% | 0.0 |
| lLN2X04 (L) | 2 | GABA | 3 | 0.9% | 0.3 |
| lLN2X12 (L) | 3 | ACh | 3 | 0.9% | 0.0 |
| lLN2X11 (L) | 1 | 5-HT | 2 | 0.6% | 0.0 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| lLN2T_e (L) | 1 | Unk | 2 | 0.6% | 0.0 |
| lLN13 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| M_imPNl92 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LHAV6b1 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| lLN2F_a (L) | 2 | GABA | 2 | 0.6% | 0.0 |
| lLN1_a (L) | 2 | 5-HT | 2 | 0.6% | 0.0 |
| vLN28,vLN29 (L) | 2 | Glu | 2 | 0.6% | 0.0 |
| M_imPNl92 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV2p1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| lLN2X03 (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| SMP142,SMP145 (R) | 1 | DA | 1 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.3% | 0.0 |
| LHAD1g1 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| DNp30 (R) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| AVLP014 (L) | 1 | Unk | 1 | 0.3% | 0.0 |
| ALIN3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| VP2+VC5_l2PN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AVLP010 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHAV2b2a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV2a1_a (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| mALB2 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| l2LN20 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHAV2g2_a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| v2LN4 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2998 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV1c2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_l2PNm14 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_lvPNm44 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2135 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV6j1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| lLN2X02 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHPV2i2b (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns CB3447 | % Out | CV |
|---|---|---|---|---|---|
| LHPV2g1 (L) | 2 | ACh | 60 | 11.7% | 0.3 |
| LHAV2b1 (L) | 4 | ACh | 41 | 8.0% | 0.5 |
| LHAV1a3 (L) | 4 | ACh | 27 | 5.3% | 0.8 |
| CB0196 (L) | 1 | GABA | 25 | 4.9% | 0.0 |
| LHAD2d1 (L) | 1 | Glu | 18 | 3.5% | 0.0 |
| CB3447 (L) | 1 | GABA | 18 | 3.5% | 0.0 |
| CB0952 (L) | 2 | ACh | 18 | 3.5% | 0.9 |
| LHAV2g2_a (L) | 3 | ACh | 17 | 3.3% | 0.2 |
| CB2005 (L) | 2 | ACh | 15 | 2.9% | 0.1 |
| LHPV6o1 (L) | 1 | Glu | 13 | 2.5% | 0.0 |
| CB1961 (L) | 2 | ACh | 13 | 2.5% | 0.4 |
| LHAD1f3b (L) | 1 | Glu | 12 | 2.3% | 0.0 |
| LHAD1g1 (L) | 1 | GABA | 11 | 2.2% | 0.0 |
| LHAD1f3a (L) | 1 | Glu | 11 | 2.2% | 0.0 |
| SIP090 (L) | 1 | ACh | 11 | 2.2% | 0.0 |
| CB2791 (L) | 1 | ACh | 9 | 1.8% | 0.0 |
| M_vPNml63 (L) | 1 | GABA | 9 | 1.8% | 0.0 |
| CB2796 (L) | 1 | ACh | 8 | 1.6% | 0.0 |
| CB2379 (L) | 1 | ACh | 7 | 1.4% | 0.0 |
| LHAD1f3c (L) | 2 | Glu | 7 | 1.4% | 0.4 |
| CB1148 (L) | 3 | Glu | 7 | 1.4% | 0.2 |
| CB2819 (L) | 1 | Glu | 6 | 1.2% | 0.0 |
| LHPV7b1 (L) | 1 | ACh | 6 | 1.2% | 0.0 |
| LHAV2g5 (L) | 1 | ACh | 6 | 1.2% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 6 | 1.2% | 0.0 |
| LHAD3g1 (L) | 2 | Glu | 6 | 1.2% | 0.3 |
| CB3092 (L) | 2 | ACh | 6 | 1.2% | 0.3 |
| CB0379 (L) | 1 | ACh | 5 | 1.0% | 0.0 |
| CB3654 (L) | 1 | ACh | 5 | 1.0% | 0.0 |
| LHAV2g2_b (L) | 2 | ACh | 5 | 1.0% | 0.6 |
| CB1457 (L) | 2 | Glu | 5 | 1.0% | 0.2 |
| LHAV3g1 (L) | 1 | Glu | 4 | 0.8% | 0.0 |
| LHPV3a1 (L) | 1 | ACh | 4 | 0.8% | 0.0 |
| LHPD4c1 (L) | 1 | ACh | 4 | 0.8% | 0.0 |
| AVLP487 (L) | 1 | GABA | 4 | 0.8% | 0.0 |
| LHPV2a1_c (L) | 2 | GABA | 4 | 0.8% | 0.5 |
| CB1874 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| CB1006 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| CB3356 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHAV6b4 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| M_l2PN3t18 (L) | 2 | ACh | 3 | 0.6% | 0.3 |
| LHAV2k8 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHPD5d1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CB1683 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHAV2d1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| APL (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| CB2714 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHAV1a1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CB2244 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| CB1149 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHPV5g1_b (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SLP230 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| MB-C1 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| LHAV2b2a (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| LHAD1b2_a,LHAD1b2_c (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| CB1843 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2b7_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2b6 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CSD (R) | 1 | 5-HT | 1 | 0.2% | 0.0 |
| M_vPNml67 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| lLN1_bc (L) | 1 | Unk | 1 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.2% | 0.0 |
| PPM1201 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| WEDPN4 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV2g3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV6c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP058 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV5a10_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| v2LN42c (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP231 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV2i1a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP003 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| M_VPNml66 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB3290 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP095 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3045 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PVLP076 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB2419 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV5b3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3294 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| M_vPNml60 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| VESa1_P02 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV2i2b (L) | 1 | ACh | 1 | 0.2% | 0.0 |